From the Publisher: The Development and Production of Biologics, Plus Addressing the Needs of the FDA
BioProcessing Journal · 27.07.2026 · 6
DOI: 10.12665/j63.kcarson ↗Kurz gefasst
Fachartikel in der Zeitschrift BioProcessing Journal, online erschienen am 27.07.2026. Verfasst von Keith L. Carson.
Abstract (Originalsprache)
In this BPJ issue, our feature article covers the 50-year history of Vero cells in vaccine applications. You’ll also learn about trends in the characterization of complex biological products, heart valve preservation, and patenting issues for single-use products. We also present the possibilities of bio-electrosprays and cell electrospinning, along with considerations for disposable chromatography. And finally, this issue delves into nanofiltration and the molecular diagnostics market. And I also want to discuss the fact that, in 2007, the U.S. federal government is continuing to starve the FDA of funding. It is time to fix this…
Zitieren
APA
Carson, K. L. (2026). From the Publisher: The Development and Production of Biologics, Plus Addressing the Needs of the FDA. BioProcessing Journal, 6. https://doi.org/10.12665/j63.kcarson
Vancouver
Carson KL. From the Publisher: The Development and Production of Biologics, Plus Addressing the Needs of the FDA. BioProcessing Journal. 2026:6. doi:10.12665/j63.kcarson
BibTeX
@article{Carson2026,
author = {Carson, Keith L.},
title = {From the Publisher: The Development and Production of Biologics, Plus Addressing the Needs of the FDA},
journal = {BioProcessing Journal},
year = {2026},
pages = {6},
doi = {10.12665/j63.kcarson}
}
EUVIMED